Lineage Cell Therapeutics In shares owned by HighTower Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by HighTower Advisors
from 13F filings
Historical chart of HighTower Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by HighTower Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $95k | 64k | 1.49 |
| 2023-12-31 | $59k | 54k | 1.09 |
| 2023-09-30 | $64k | 54k | 1.18 |
| 2023-06-30 | $48k | 34k | 1.41 |
| 2023-03-31 | $75k | 50k | 1.50 |
| 2022-12-31 | $40k | 34k | 1.17 |
| 2022-09-30 | $37k | 33k | 1.11 |
| 2022-06-30 | $53k | 33k | 1.59 |
| 2022-03-31 | $51k | 33k | 1.53 |
| 2021-12-31 | $82k | 33k | 2.45 |
| 2021-09-30 | $84k | 33k | 2.52 |
| 2021-06-30 | $46k | 16k | 2.82 |
| 2021-03-31 | $38k | 16k | 2.33 |
| 2020-12-31 | $28k | 16k | 1.72 |